Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age

P. Lankisch, R. Wessalowski, P. Maisonneuve, M. Haghgu, D. Hermsen, C. M. Kramm

Research output: Contribution to journalArticle

Abstract

Background. Monitoring renal function is crucial in children undergoing chemotherapy. To date, a combination of routine serum creatinine (SCR) monitoring with occasional determination of creatinine clearance ratio (CCR) is widely used as clinical standard for this purpose. Both methods have their limitations regarding diagnostic value (SCR) or practicability (CCR), especially in young children. Diagnostic alternatives, such as glomerular filtration rate (GFR) estimation formulas have not been proved to be superior. The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients. Procedure. CysC, SCR, several GFR estimation formulas (Counahan-Barratt, Ghazali-Barratt, Schwartz, Shull, Traub), and CCR were studied in 80 pediatric cancer patients (age range: 0.17-17.9 years) during their chemotherapy. Special attention was given to children under the age of 3 in whom accurate urine collection for CCR is difficult. Results. All parameters correlated similarly well with CCR. Total accuracy was 66% and 67% for CysC and SCR, respectively. In very young children (

Original languageEnglish
Pages (from-to)767-772
Number of pages6
JournalPediatric Blood and Cancer
Volume46
Issue number7
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Cystatin C
Creatinine
Pediatrics
Kidney
Serum
Neoplasms
Glomerular Filtration Rate
Drug Therapy
Urine Specimen Collection

Keywords

  • Cystatin C
  • Estimation of GFR
  • Pediatric oncology

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age. / Lankisch, P.; Wessalowski, R.; Maisonneuve, P.; Haghgu, M.; Hermsen, D.; Kramm, C. M.

In: Pediatric Blood and Cancer, Vol. 46, No. 7, 06.2006, p. 767-772.

Research output: Contribution to journalArticle

@article{8889cc59d2ff484e9851eef01a534fe3,
title = "Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age",
abstract = "Background. Monitoring renal function is crucial in children undergoing chemotherapy. To date, a combination of routine serum creatinine (SCR) monitoring with occasional determination of creatinine clearance ratio (CCR) is widely used as clinical standard for this purpose. Both methods have their limitations regarding diagnostic value (SCR) or practicability (CCR), especially in young children. Diagnostic alternatives, such as glomerular filtration rate (GFR) estimation formulas have not been proved to be superior. The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients. Procedure. CysC, SCR, several GFR estimation formulas (Counahan-Barratt, Ghazali-Barratt, Schwartz, Shull, Traub), and CCR were studied in 80 pediatric cancer patients (age range: 0.17-17.9 years) during their chemotherapy. Special attention was given to children under the age of 3 in whom accurate urine collection for CCR is difficult. Results. All parameters correlated similarly well with CCR. Total accuracy was 66{\%} and 67{\%} for CysC and SCR, respectively. In very young children (",
keywords = "Cystatin C, Estimation of GFR, Pediatric oncology",
author = "P. Lankisch and R. Wessalowski and P. Maisonneuve and M. Haghgu and D. Hermsen and Kramm, {C. M.}",
year = "2006",
month = "6",
doi = "10.1002/pbc.20581",
language = "English",
volume = "46",
pages = "767--772",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Serum cystatin C is a suitable marker for routine monitoring of renal function in pediatric cancer patients, especially of very young age

AU - Lankisch, P.

AU - Wessalowski, R.

AU - Maisonneuve, P.

AU - Haghgu, M.

AU - Hermsen, D.

AU - Kramm, C. M.

PY - 2006/6

Y1 - 2006/6

N2 - Background. Monitoring renal function is crucial in children undergoing chemotherapy. To date, a combination of routine serum creatinine (SCR) monitoring with occasional determination of creatinine clearance ratio (CCR) is widely used as clinical standard for this purpose. Both methods have their limitations regarding diagnostic value (SCR) or practicability (CCR), especially in young children. Diagnostic alternatives, such as glomerular filtration rate (GFR) estimation formulas have not been proved to be superior. The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients. Procedure. CysC, SCR, several GFR estimation formulas (Counahan-Barratt, Ghazali-Barratt, Schwartz, Shull, Traub), and CCR were studied in 80 pediatric cancer patients (age range: 0.17-17.9 years) during their chemotherapy. Special attention was given to children under the age of 3 in whom accurate urine collection for CCR is difficult. Results. All parameters correlated similarly well with CCR. Total accuracy was 66% and 67% for CysC and SCR, respectively. In very young children (

AB - Background. Monitoring renal function is crucial in children undergoing chemotherapy. To date, a combination of routine serum creatinine (SCR) monitoring with occasional determination of creatinine clearance ratio (CCR) is widely used as clinical standard for this purpose. Both methods have their limitations regarding diagnostic value (SCR) or practicability (CCR), especially in young children. Diagnostic alternatives, such as glomerular filtration rate (GFR) estimation formulas have not been proved to be superior. The aim of the study was to evaluate whether serum cystatin C (CysC) may have a diagnostic impact on pediatric patients. Procedure. CysC, SCR, several GFR estimation formulas (Counahan-Barratt, Ghazali-Barratt, Schwartz, Shull, Traub), and CCR were studied in 80 pediatric cancer patients (age range: 0.17-17.9 years) during their chemotherapy. Special attention was given to children under the age of 3 in whom accurate urine collection for CCR is difficult. Results. All parameters correlated similarly well with CCR. Total accuracy was 66% and 67% for CysC and SCR, respectively. In very young children (

KW - Cystatin C

KW - Estimation of GFR

KW - Pediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=33646587660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646587660&partnerID=8YFLogxK

U2 - 10.1002/pbc.20581

DO - 10.1002/pbc.20581

M3 - Article

C2 - 16550534

AN - SCOPUS:33646587660

VL - 46

SP - 767

EP - 772

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -